BMS-986104

DB15214InvestigationalSmall molecule

BMS-986104 is under investigation in clinical trial NCT02211469 (A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986104 in Healthy Male Subjects).

Formula / weight: C₂₂H₃₅NO · 329.528 g/mol (avg)
Code names: BMS-986104

Resolves to

Compound

UNIIKJ9D084FO4CAS1622180-31-7ChEMBLCHEMBL3806158

Structure

InChIKeyBPMMYKAHRIEVDH-VOQZNFBZSA-NSMILESCCCCCC[C@@H]1CCC2=C(C1)C=CC(=C2)[C@H]1CC[C@](N)(CO)C1

Targets

P21453S1PR1

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with BMS-986104, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account